Next Article in Journal
Policies and Toxicological Screenings for No Drug Addiction: An Example from the Civil Aviation Workforce
Previous Article in Journal
On the Supervision of a Saturated SIR Epidemic Model with Four Joint Control Actions for a Drastic Reduction in the Infection and the Susceptibility through Time
Previous Article in Special Issue
Do Cognitive Abilities Influence Physical and Mental Fatigue in Patients with Chronic Pain after Walking According to a Clinical Guideline for Physical Exercise?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pain-Related Worrying and Goal Preferences Determine Walking Persistence in Women with Fibromyalgia

by
María Ángeles Pastor-Mira
1,
Sofía López-Roig
1,*,
Eva Toribio
2,
Fermín Martínez-Zaragoza
1,
Ainara Nardi-Rodríguez
1 and
Cecilia Peñacoba
3
1
Department of Behavioral Sciences and Health, University Miguel Hernández, 03540 San Juan de Alicante, Spain
2
Fibromyalgia Unit, Hospital of San Vicente del Raspeig, 03690 Alicante, Spain
3
Department of Psychology, Rey Juan Carlos University, 28922 Madrid, Spain
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(3), 1513; https://doi.org/10.3390/ijerph19031513
Submission received: 15 December 2021 / Revised: 21 January 2022 / Accepted: 26 January 2022 / Published: 28 January 2022
(This article belongs to the Special Issue Adherence to Physical Exercise in Patients with Chronic Diseases)

Abstract

:
Physical activity and exercise are relevant behaviors for fibromyalgia health outcomes; however, patients have difficulties undertaking and maintaining an active lifestyle. With a cross-sectional design, this study explored the role of pain-related worrying and goal preferences in the walking persistence of women with fibromyalgia. The sample included 111 women who attended a tertiary health setting. We adapted the Six-Minute Walk Test where participants decided either to stop or continue walking in five voluntary 6 min bouts. Women who were categorized higher in pain-related worrying reported higher preference for pain avoidance goals (t = −2.44, p = 0.02) and performed worse in the walking task (LongRank = 4.21; p = 0.04). Pain avoidance goal preference increased the likelihood of stopping after the first (OR = 1.443), second (OR = 1.493), and third (OR = 1.540) 6 min walking bout, and the risk of ending the walking activity during the 30 min task (HR = 1.02, [1.0–1.03]). Influence of pain-related worrying on total walking distance was mediated by goal preferences (ab = −3.25). In interventions targeting adherence in physical activity and exercise, special attention is needed for women who are particularly worried about pain to help decrease their preference for short-term pain avoidance goals relative to long-term goals such as being active through walking.

1. Introduction

Fibromyalgia is characterized by chronic widespread musculoskeletal pain and fatigue, among other symptoms such as nonrestorative sleep, anxiety, depression, and attention and memory disturbances. The etiology of fibromyalgia remains unknown, and its diagnosis is clinical and not based on objective tests [1,2,3]. Patients with fibromyalgia, usually show high functional impact and negative consequences in their quality of life, along with a high sociosanitary burden [2]. Regarding this health problem, with multiple psychological and physical symptoms, the best treatment approach includes physical, pharmacological, and psychological strategies [3,4], with the objective of improving physical and psychosocial functioning. For these patients, being physically active and doing exercise is widely recommended due to the positive effects it has on their physical function and quality of life among other health outcomes [4,5,6,7,8,9,10,11,12]. In fact, exercise is the initial recommended treatment in a graded strategy of intervention [4]. Walking is an effective form of exercise; it is easy and accessible with low musculoskeletal impact and it has been associated with improvements in cardiovascular disease risk factors, increasing aerobic capacity, reducing systolic and diastolic blood pressure, waist circumference, weight, and a decrease in both body fat and body mass index [13,14]. In addition, walking has shown positive effects on pain and physical function and it is recommended for people with chronic musculoskeletal pain such as fibromyalgia [15]. However, women with fibromyalgia are less physically active than others [16]. A high proportion present a sedentary lifestyle [10,17], impaired subjective and objective physical function [18], and low adherence to unsupervised walking exercise [19]. Exercise health benefits are undermined when patients do not maintain their routines [20]; however, long-term exercise adherence continues to be a clinical challenge when taking into account previous research [21,22]. In fact, some authors have suggested walking as a form of exercise along with strategies aimed at maintaining patients’ participation [15].
Both undertaking and maintaining exercise in chronic pain involve a self-regulation drive where motivational perspectives could be relevant. In line with the fear-avoidance model [23], people with pain can anticipate negative consequences from physical activity or exercise, such as a worsening of the pain. Furthermore, the fear associated with these expected consequences lead to avoiding physical activity or exercise in order to try to prevent pain. In fibromyalgia, some authors have shown that fear of movement and avoidance behavior toward physical activity is highly prevalent [24]. The fear of movement and the subsequent avoidance behavior often happens as a result of catastrophizing worries about pain and its consequences. The fear-avoidance model has been enhanced by adopting a motivational perspective, which states that people with chronic pain are faced with multiple competing goals and they should prioritize between those related to resolving and avoiding pain and those related to maintaining or incorporating other important goals different from pain control [25,26,27,28]. Strong achievement goals may reduce avoidance behavior [25,29] or increase patients’ persistence in painful physical activities [30]. In this vein, the preference for competing goals such as being active and pain avoidance could play a main role in undertaking and maintaining physical activity and exercise in patients with fibromyalgia.
From this motivational approach, pain catastrophizing would reflect the concern about pain interference in goals other than pain control and it would not be grounded in psychopathology approaches [25]. In this regard, Crombez et al. [31] have shown that the content of pain catastrophizing self-reported measures is closer to a pain-related worrying construct than a catastrophizing construct. On the other hand, the term “pain catastrophizing” has been labeled as negative and stigmatizing [32]. Due to these concerns and the suggestion of several authors [25,31] we will use the term “pain-related worrying” synonymously.
In women with fibromyalgia, pain is a reported obstacle for walking exercise [33] and the goal of avoiding it can compete with the goal of undertaking the exercise. This issue is more relevant for patients highly worried about their pain. Therefore, they are more likely to prefer pain avoidance goals than low pain catastrophizing patients, who would be more likely to get involved in long-term achievement goals, such as maintaining walking in the context of doing exercise (more goal persistence and, therefore, more adherence). Hence, pain catastrophizing could have an influence on exercise behavior through the patients’ goal preferences. The relevance of catastrophizing in chronic pain and fibromyalgia has been highlighted [34,35,36,37,38,39,40]. Recently, some authors have shown pain catastrophizing as a moderator in fibromyalgia pain intensity and physical activity relationships [41]. However, to the best of our knowledge, little is known about its role in undertaking and, mainly, maintaining walking exercise, taking into account its possible influence on habitual patients’ goal preferences.
Owing to the relevance of physical activity and exercise in fibromyalgia health outcomes, patients’ difficulties in maintaining exercise, and the influence of catastrophizing and goal preferences on physical activity, this study aimed to explore their joint role in the walking persistence in women with fibromyalgia. We expected that pain-related worrying would lead to an increased pain avoidance goal preference relative to physical activity and exercise achievement goals, and to less persistence in a walking physical activity task.

2. Materials and Methods

2.1. Participants

A total of 111 women who attended the Fibromyalgia Unit (FU) of the Valencian Community (San Vicente del Raspeig Hospital) participated in this study. The mean age was 51.4 (SD = 9.7). Most were married (69.4%; n = 77), with primary (46.8%; n = 52) or secondary studies (38.7%; n = 43). At the time of the study, 19.8% of participants worked outside the home (n = 22), 26.1% were on sick leave (n = 29), 25.2% were unemployed (n = 28), 23% were housewives (n = 23), and 7.2% were retired (n = 8). The mean time from the first symptoms was 14.1 years (SD = 9.8) and from diagnosis was 6.2 years (SD = 6.2). The mean pain intensity perception was 6.8 (out of 10; SD = 1.7) and the mean of the perceived fibromyalgia impact was 72.3 (out of 100; SD = 15.8) (Table 1).

2.2. Variables and Instruments

Sociodemographic and clinical variables were measured with ad hoc questions.
Pain catastrophizing: We used the total score of the Spanish validation [40] of the Pain Catastrophizing Scale (PCS) [42]. This scale contains 13 items answered on a 5-point Likert scale from 0 (not at all) to 4 (all the time) (rank 0–52) and assesses three dimensions: rumination (focusing excessively on pain sensations), magnification (tendency to magnify the threat value of pain sensations), and helplessness (to perceive oneself as unable to control pain). A higher PCS total score represents higher pain catastrophizing (α = 0.95). As highlighted in the introduction, recent research has shown the content of this construct is better represented by pain-related worrying [31].
Pain intensity: Measured with the mean score of the maximum, minimum, and usual pain intensity during the last week and pain intensity at time of the assessment. Items were answered with an 11-point numerical rating scale (0 = “no pain at all” and 10 = “the worst pain you can imagine”) adapted from Jensen et al. [43]. The scale has shown strong psychometric properties in Spanish FM samples [44,45]. High mean scores indicate high pain intensity (α = 0.86). As the pain intensity at the time of the assessment may determine the walking performance more than the general pain intensity, we also used this single item as another measure of pain (pain intensity before the task).
Fatigue intensity before the task: With a single item answered on an 11-point numerical rating scale (0 = “no fatigue at all” and 10 = “the worst fatigue you can imagine”) we measured fatigue perception before starting the walking task.
Goal preferences: We used the adapted version for physical activity and exercise (GPQ-PA) [46] of the Spanish version [47] of the Goal Pursuit Questionnaire (GPQ) [29]. The GPQ assesses the habitual goal pursuit of people with pain, taking into account pain avoidance short-term goals relative to achievement or long-term goals (related to different tasks), which can be activated at the same time in one situation. Following the same GPQ design and wording [29], we considered physical activity and exercise as achievement goals in five physical activity situations. Therefore, the GPQ-PA is comprised of five items that each include a vignette with a situation related to physical activity and exercise: (1) walking while taking advantage of other daily activities, (2) brisk walking for exercising at least 30 min, and undertaking (3) light, (4) moderate, and (5) vigorous physical activity intensities with the aim of exercising. The participants must imagine themselves, as vividly as possible, in the presented situation. Each vignette (i.e.,: “While you are walking taking advantage of going to work, shopping or taking the dog out, your body becomes increasingly painful. You are expected to complete your walking route today”) is followed by a sentence showing a thought which indicates a goal preference (i.e.,: “I think it is more important to reduce my pain now than to finish this walking route”) that the participant must rate on a 6-point Likert scale (1 = strongly disagree, 6 = strongly agree). The more agreement, the higher the preference for avoiding pain (short-term goal) versus finishing the activity (long-term goal). Higher mean scores indicate stronger preferences for pain avoidance goals relative to physical activity and exercise achievement goals. The GPQ-PA internal consistency in this sample was α = 0.87.
Fibromyalgia impact: We used the Spanish adaptation of the Revised Fibromyalgia Impact Questionnaire (FIQ-R) [48] to measure the perceived health impact of fibromyalgia, in terms of function (9 items), overall impact (2 items), and symptoms (10 items). Items are answered on an 11-point numerical rating scale from 0 to 10, with different wording anchors depending on the item. The total score of fibromyalgia impact is also obtained (rank 0–100). Higher scores represent a higher impact on quality of life (α = 0.90).
Physical activity: Total MET minutes/week was used as an indicator of previous physical activity, measured by the International Physical Activity Questionnaire-Short Form (IPAQ-S) [49]. Items ask respondents to report the frequency and duration of walking, moderate and vigorous physical activity intensity, performed for at least 10 min per session in the last week. We used the total MET minutes/week, which is the score of metabolic equivalence of minutes/week spent overall on physical activity.
Walking persistence: We used the Six-Minute Walk Test (6MWT), which is a clinically relevant objective measure of the physical function recommended in fibromyalgia [50] and is regarded as a feasible and valid submaximal exercise test [51]. It records the distance that each participant can quickly walk on a 30 m flat surface in a period of 6 min. We adapted the 6MWT in order to get a measure of walking persistence taking into account the content of the task-contingent persistence behavioral pattern, which is defined as “behavioral persistence in finishing tasks or activities despite pain” and is considered to be an adaptive behavioral activity pattern different from the excessive persistence [52,53]. We adopt this walking task measure as a proxy of adherence.
In our adaptation (see design section), participants decide to stop or continue walking in each bout of 6 min with a maximum duration of 30 min (for five bouts). We measure three variables as different indicators of walking persistence: (1) decision making: stopping vs. following walking through each 6 min bouts was used to operationalize the conscious decision aimed at persistence in walking; (2) total number of complete laps (each lap 60 m), which allows us to conduct a survival analysis (see statistics section) but is more inaccurate than the (3) total walking distance, which is registered as a continuous variable (total meters walked, including those in the last possible incomplete lap). The two latter variables were used to operationalize performance in the walking task.
When participants finished the walking task, they were asked for their reasons for definitively leaving the test.

2.3. Design and Procedure

This research was approved by the Ethic Committees of the Alicante General Hospital and the Miguel Hernández University and corresponds to the third study of a broader work, which aims to identify a physical activity and exercise self-regulation model in women with fibromyalgia in rehabilitation settings. Informed consent was obtained from all subjects involved in the study. Inclusion criteria was: women, aged between 18 and 70 years, with a fibromyalgia diagnosis confirmed by the physicians of the FU, following ARA criteria [54], with the ability to properly fill out the self-reported measures, without problems or comorbidity preventing walking and with the adequate physical conditions to perform the 6MWT (contraindications include unstable angina or myocardial infarction in the previous month, resting heart rate of >120, systolic blood pressure of 180 mmHg, or diastolic blood pressure >100 mmHg, and oxygen saturation of >90) [55]. A consecutive selection of the 121 FU patients who met the inclusion criteria was performed; they were invited to participate in the study and 118 accepted and signed the informed consent. Of those women, 3 patients did not meet the specific criteria to perform the 6MWT, 2 patients refused to continue once the task started (one woman felt anxiety during the task, and one stopped because she had no more time), and 2 patients’ data were eliminated due to mistakes in the data recording. Therefore, the sample was composed of 111 women. The period of recruitment spanned from July 2019 to February 2020.

2.4. Research Design

This is an observational cross-sectional study performed at the FU setting. Research design was thought (1) to establish a valued goal context for patients, and (2) to resemble a test of walking persistence, based on individual decision.
Both at the first and the last individual medical interview in the FU, patients were examined by the doctor to test the standard criteria for the 6MWT performance. Likewise, the doctor informed about the 6MWT as another component of the patients’ assessment in the FU, provided motivational instructions about the relevance of the 6MWT task for their assessment and advised patients to walk as far as they could and in the longest time possible between 6 min and 30 min (valued goal context). The time of 30 min was established as it is the minimum walking exercise time recommended for women with fibromyalgia in our research [56].
Afterwards, the patients completed the questionnaires with the help of the researcher (pre-test assessment) and performed the 6MWT. Following the standard administration, they were instructed to walk as far as they could and as fast as they could, but in a way that was comfortable to them. Therefore, the women decided their walking speed and, as is usual in the 6MWT, took minor breaks during the task. We used the standard 6MWT application sequence. However, we slightly modified the instructions at the end of every 6 min walking bout, asking patients if they wanted to do another 6 min of walking (“…could you repeat 6 min more, do you want to do it?”) until a maximum of five bouts had been completed.
The researchers who applied the 6MWT were different from those who were applying the pre-test assessment. They were unaware of the research hypothesis. The researchers who applied the 6MWT were also unaware of the scores in pain catastrophizing, goal preferences, and the other measures obtained in the pre-test.

2.5. Statistics

The SPSS v25 was used for analysis. Firstly, we performed descriptive, parametric, and nonparametric analyses of differences between women who were categorized as high and low based on their scores in PCS. Although PCS is designed to assess pain catastrophizing as a continuous variable, some authors have used a median split approach to identify high and low pain-catastrophizing patients. Taking into account the score distribution in our sample and the data reported by other authors [38,57,58,59], we used the median-split criteria only for comparison analysis, where scores ≤31 and >31 indicate low and high pain catastrophizing or pain-related worrying, respectively.
Secondly, logistic regression analyses were conducted to explore the differences between patients who decided to stop vs. those who followed through walking at the end of each 6 min bout (decision making). Hence, the binary outcome variable was stopping vs. continuing walking. Odds ratios (OR) and 95% CI were calculated. In addition, we examined pain-related worrying (using PCS total score) and goal preferences controlling sociodemographic, physical activity, and clinical variables. For each bout, we carried out a preselection process of variables with univariate analyses exploring age, educational level, occupational status, civil status, duration of problem, time since diagnosis, overall pain intensity, pain and fatigue intensity before the task, fibromyalgia impact, and MET minutes/week. Variables associated with outcome at p (Wald) values <0.20 in univariate analyses were included in a multivariate logistic model. As a result of the high correlation between measures and the Tolerance and VIF index values, the collinearity effects were controlled, including fibromyalgia impact and removing pain intensity. We used the forward and backward step likelihood ratio (LR) method as it has been recommended to select the best model applying the criteria of Mallow’s Cp adapted by Hosmer and Lemeshow [60].
Thirdly, using the total number of laps variable, we performed a survival analysis to explore the association between catastrophizing and the probability of following through with walking along the 30 min of the task. Stopping walking was specified as the “event” and the total number of laps walked was specified as “survival time”. Women who reached the 30 min walking distance at the end of the test were considered “free from the event” and, then, as “right censored observations”. We carried out two survival analysis: (1) the Kaplan–Meier method to estimate the walking survival functions, comparing the equality of walking survival distributions for the high and low pain catastrophizing groups using the LongRank test (Mantel–Haenszel); and (2) a multivariate Cox regression analysis was performed to model the hazard function to predict the probability of stopping at a number of laps. We introduced pain-related worrying and goal preferences, controlling sociodemographic and clinical variables. These variables were selected taking into account that p ≤ 0.20 in previous univariate was applied. A forward stepwise was the method to estimate the final model and the p value of each variable with the likelihood ratio test.
Finally, with the walking distance variable, we determined to what extent pain-related worrying and goal preference influenced total walking distance covered, using the PROCESS macro, version 3.4.1 [61]. A simple mediation model (model 4) was tested with goal preference as a mediator, controlling sociodemographic, physical activity, and clinical variables. Inference about the direct effect of catastrophizing on total walking distance is framed in terms of a null hypothesis test.
Goal preference is formulated by constructing a bootstrap confidence interval, using the bootstrapping method with 10.000 samples and seeding the random number generator.

3. Results

Table 1 shows descriptive and difference analysis between patients with low and high scores on pain-related worrying. The mean score of pain-related worrying was 30.9. Significant differences between groups were found on pain intensity (t = −4.68, p = 0.0001), fibromyalgia impact (t = −4.46, p = 0.0001), goal preferences (t = −2.44, p = 0.02), total walking distance (t = 2.05, p = 0.04), and number of laps (t = 2.07, p = 0.04).

3.1. Decision Making about Stopping or Following through with Walking Each 6 Min Bout

All participants walked the first 6 min bout. Forty-six women (41.4%) decided to stop the task at the end of the first bout and 65 women followed through with the second bout. Only 13 women (11.7%) completed the 30 min task (Table 1). The three most frequent reasons for leaving the test were fatigue (40.0%), pain (25.5%), and poor physical conditions (dizziness, difficulties with breathing, and trembling, among others) (11.9%). Pain was a more common reason in the high pain pain-related worrying group (37.5%, n = 21) than in the low pain group (12.7%, n = 7).
Univariate logistic analysis results showed selected goal preferences, pain-related worrying, educational level, fibromyalgia impact, pain and fatigue before task, and MET minutes/week. Results of the step methods and the selection of the best predictive model showed that the more pain-avoidance goal preferences (OR = 1.443 [1.026–2.030]), the more fibromyalgia impact (OR= 1.029 [1.000–1.060]) and a higher educational level (OR = 2.428 [1.055–5.589]) increased the probability of stopping vs. walking after the first bout.
Goal preferences was the only variable which increased the likelihood of stopping after the second (OR = 1.493 [1.092–2.042]) and the third bout (OR = 1.540 [1.073–2.210]). No significant predictors were found after the fourth bout (Table 2).

3.2. Walking Performance along the Walking Task

3.2.1. Total Number of Complete Laps: Survival Analysis

The mean number of laps was 14.3 (SD = 10.6) (range: 2–46) (Table 1). Analysis of the walking survival functions showed that the number of laps walked was higher for women with low scores on PCS than women with high scores (LongRank = 4.21; p = 0.04) (Figure 1).
However, pain-related worrying was not a significant predictor of walking persistence. As a result of univariate Cox regression analyses we explored goal preferences, pain-related worrying, age, fibromyalgia impact, and MET minutes/week. The estimated hazard ratios of the Cox regression analysis indicated that the risk of stopping walking increased as did the pain-avoidance goal preference score (HR = 1.29 [1.09–1.52], p = 0.002), controlling the fibromyalgia impact (HR = 1.02, [1.0–1.03], p = 0.014) (χ2 = 14.85, p = 0.001).

3.2.2. Total Walking Distance: Mediational Model of Pain-related Worrying through Goal Preference

Given that fibromyalgia impact was a significant predictor of walking performance in terms of total distance covered, it was introduced in the analysis as a covariate. The total effect of the model was significant (F = 6.00, p = 0.003). The direct effect of the pain-related worrying total score on walking total distance was not significant (c’ = −2.33, p = 0.680). However, we found a significant indirect effect through pain-avoidance goal preference (ab = −3.25 [−8.27–−0.060]) (Figure 2).

4. Discussion

Being physically active and doing exercise are well-documented practices for patients with fibromyalgia [6,62,63]. In fact, they are core treatment recommendations for this chronic pain problem and should be applied, tailored, graded, and progressed slowly while taking into account the patients’ exercise preferences and experiences [4,7]. Previous studies have shown that patients with fibromyalgia are motivated to engage in exercise [21,33] and start with this practice, but they usually do not follow through with it [21,22]. Therefore, as mentioned, physical activity and exercise maintenance appears to be a relevant clinical challenge. Consequently, in women with fibromyalgia who attended out-patient rehabilitation clinics, this study aimed to identify the encompassing role of pain-related worrying and goal preferences on walking persistence, taking into account the motivational reformulation of the fear avoidance model [25,26,27,28]. For this purpose we adapted the 6MWT to achieve a self-regulation frame and a maximum performance of 30 min, which is the minimum time recommended for walking exercise in our research [19,21,56].
As hypothesized, pain-related worrying introduced significant differences in goal preferences and walking persistence with the physical activity task. Women categorized as being high in pain-related worrying showed a stronger preference for pain avoidance goals relative to physical activity and exercise achievement goals, and worse performance in the physical activity task. However, the pain-related worrying did not play any role in the personal decision aimed at walking persistence. Although higher fibromyalgia impact, higher educational level, and the preference for pain-avoidance goals were significant predictors of stopping at the first bout, only goal preferences predicted the likelihood of stopping in the two following bouts. None of the included variables predicted the last decision to stop vs. to continue with the task, probably due to the few number of patients who reached this bout. The habitual preference for the pain-avoidance goal was also the main predictor of the task performance taking into account the number of laps. These results are in line with the tested mediational model, where pain-related worrying did not directly influence walking performance, but rather indirectly through the goal preferences, supporting a motivational explanation for walking maintenance in these patients. Moreover, it is in line with previous studies that have highlighted the association between pain catastrophizing and both the hedonic goal of avoiding pain or the assimilative way of coping which focuses the patients’ efforts on finding a solution to their pain problem [29,64,65]. Note that participants had a long-lasting pain and were diagnosed with fibromyalgia around six years ago. Despite this, taking into account their strong endorsement of pain-avoidance goals and the relationships of goal preferences with pain-related worrying, the patients appeared more perseverant in solving their insoluble chronic pain problems instead of focusing on different goals, such as exercising. In this vein, only a low proportion of patients (around 12%) completed the 30 min walking task. Fatigue and pain were the main reasons for abandoning the task and primarily pain in women with high pain-related worrying. Moreover, symptoms and illness impact were not associated with goal preferences but with pain-related worrying which, in turn, aims to avoid pain. Such results have implications on psychological interventions, as independently of the clinical situation of patients, it is possible to modify goal preferences targeting realistic and healthy aims such as physical activity and exercise.
Previous research using the original GPQ in people with different pain complaints has shown that endorsing either an achievement or pain-avoidance goals was associated with more disability [29]. In women with fibromyalgia, pain catastrophizing has shown a direct influence on self-reported disability and health impact, whereas the pain-avoidance goal preferences have shown an indirect influence through the activity avoidance pattern on the same variables [47]. Hence, the present study adds evidence about the role of these constructs in fibromyalgia showing, first of all, an indirect mechanism for pain-related worrying in the walking persistence and, secondly, the close link between goal preferences and behavior in these patients. Our findings have shown that pain-avoidance goal preferences influenced a more specific and objective way of avoidance behavior related to walking. Therefore, goal preferences appear to be a proximal determinant of the fibromyalgia patients’ physical activity behavior. Patients’ goal preference should be explored by health care providers when they prescribe physical activity and exercise, in order to adjust patients’ expectations about their symptoms when they undertake the activity and prevent both avoidance and escape behaviors.
The contribution of pain catastrophizing on disability and other health outcomes is well documented [34,37,38,58,66]. Moreover, in women with fibromyalgia, pain catastrophizing has been relevant in explaining the discordance between objective and subjective measures of physical function [18] and the patients’ physical fitness and active lifestyle [9]. However, to the best of our knowledge, there are few studies exploring specifically how catastrophizing influences physical activity and exercise or walking. Recently, Lazaridou and colleagues [41], using electronic diaries and a step count, found that increases in daily physical activity was associated with more pain intensity in women with fibromyalgia, mainly in those with a higher rate of catastrophizing. Hence, pain catastrophizing shows different ways of influence on physical activity and it is worth conducting further research about its role on walking exercise, mainly considering new recommendations about its assessment [31]. In women with fibromyalgia, from a motivational approach, the roles of catastrophizing and goal preferences have been explored in functional limitations. However, fatigue avoidance was one of the goal preferences relative to other achievement goals focused on several daily life tasks (work and homework) [67].
Taking into account descriptive data, women of this study reported high chronicity, pain intensity, fatigue, and fibromyalgia impact perception. Furthermore, participants scored high in pain-related worrying and showed a strong preference for short-term pain avoidance goals relative to physical activity and exercise long-term achievement goals. It is worth underlining that the decision to stop and performance in the walking task depended mainly on the patients’ goal preferences and not on chronicity and perceived symptoms, despite those symptoms being a reason to abandon the task. This finding is not in line with previous results where symptoms made significant contributions to physical fitness and physical activity [10,68,69]. Finally, fibromyalgia impact perception showed a significant relationship with walking performance in the same vein of previous research conducted with the 6MWT [51,70].
We should bear in mind some study limitations. First, the study has been conducted only with women who attended the tertiary level of health care, focused on rehabilitation treatment; hence, we should aim to replicate these findings in other patients with fibromyalgia. Second, the walking task was conducted inside the FU and is not fully representative of habitual walking activity or exercise. It is performed without natural stimuli that women may find outside; moreover, the task is performed in a repetitive manner, which could be considered dull and may potentially increase their likelihood of dropping out, although this was not a reported reason in this case. Finally, mediation analysis was cross-sectional and causation cannot be inferred. Furthermore, despite the statistical significance of some of its parameters, the total values were found to be low. Moreover, the number of statistical tests conducted could be considered excessive due to our sample size. Nevertheless, logistic and Cox regression and mediational model analyses are thought to explore different perspectives of the association of pain catastrophizing and goal preferences, and the results are coherent through them. Conversely, there are several strengths to highlight, such as the novel procedure of adapting a well-documented test (the 6MWT), the obtained objective measures, and the support for the main role of pain-related worrying in these women also in physical activity tasks. Our results show that its influence on walking persistence is mediated by the preference for short-term goals, such as pain avoidance, relative to physical activity and exercise long-term achievement goals, putting walking behavior in the motivational context of competing goals.

5. Conclusions

In fibromyalgia it is recommended to use individually tailored exercise programs [7] and, in this vein, health care professionals should take into account not only physical variables, but also motivational variables related to worries and goal preferences, because avoiding pain and maintaining exercise compete with each other in the context of physical activity tasks. Targeting physical activity and exercise implies working to reduce pain-related worrying and increases the value and commitment to physical activity and exercise goals.

Author Contributions

Conceptualization and methodology, M.Á.P.-M., S.L.-R. and C.P.; software, S.L.-R. and A.N.-R.; formal analysis, S.L.-R. and M.Á.P.-M.; investigation, S.L.-R., E.T. and M.Á.P.-M.; data curation, S.L.-R. and A.N.-R.; writing—original draft preparation, M.Á.P.-M. and S.L.-R.; writing—review and editing, M.Á.P.-M., S.L.-R., F.M.-Z., E.T., A.N.-R. and C.P.; supervision, M.Á.P.-M. and S.L.-R.; project administration and funding acquisition, M.Á.P.-M., S.L.-R. and C.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Spanish Ministry of Economy and Competitiveness (grant PSI2016-79566-C2-1-R), Spain.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committees of the Alicante General Hospital (PSI2016-79566-C2-1-R, date of approval 30 November 2016) and the Miguel Hernandez University (DPS.MPM.02.16, date of approval 20 December 2016).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data are available by request to the corresponding author ([email protected]).

Acknowledgments

The authors are very grateful to the women with fibromyalgia who agreed to participate in the study, as well as to the professionals of the Fibromyalgia Unit of the Community of Valencia (San Vicente del Raspeig Hospital) for their support throughout the research period. The Cecilia Peñacoba contribution was supported by the Instituto de Salud Carlos III (grant PI17/00858), Spain.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Arnold, L.M.; Choy, E.; Clauw, D.J.; Goldenberg, D.L.; Harris, R.E.; Helfenstein, M.; Jensen, T.S.; Noguchi, K.; Silverman, S.L.; Ushida, T.; et al. Fibromyalgia and chronic pain syndromes: A white paper detailing current challenges in the field. Clin. J. Pain 2016, 32, 737–746. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Häuser, W.; Ablin, J.; Fitzcharles, M.A.; Littlejohn, G.; Luciano, J.V.; Usui, C.; Walitt, B. Fibromyalgia. Nat. Rev. Dis. Prim. 2015, 1, 15022. [Google Scholar] [CrossRef] [PubMed]
  3. Sarzi-Puttini, P.; Giorgi, V.; Marotto, D.; Atzeni, F. Fibromyalgia: An update on clinical characteristics, aetiopathogenesis and treatment. Nat. Rev. Rheumatol. 2020, 16, 645–660. [Google Scholar] [CrossRef]
  4. Macfarlane, G.J.; Kronisch, C.; Dean, L.E.; Atzeni, F.; Häuser, W.; Flub, E.; Choy, E.; Kosek, E.; Amris, K.; Branco, J.; et al. EULAR revised recommendations for the management of fibromyalgia. Ann. Rheum. Dis. 2017, 76, 318–328. [Google Scholar] [CrossRef] [PubMed]
  5. Andrade, A.; Dominski, F.H.; Sieczkowska, S.M. What we already know about the effects of exercise in patients with fibromyalgia: An umbrella review. Semin. Arthritis Rheum. 2020, 50, 1465–1480. [Google Scholar] [CrossRef]
  6. Bidonde, J.; Busch, A.J.; Schachter, C.L.; Webber, S.C.; Musselman, K.E.; Overend, T.J.; Góes, S.M.; Dal Bello-Haas, V.; Boden, C. Mixed exercise training for adults with fibromyalgia. Cochrane Database Syst. Rev. 2019, 2019. [Google Scholar] [CrossRef]
  7. Bidonde, J.; Boden, C.; Foulds, H.; Kim, S.Y. Physical Activity and Exercise Training for Adults with Fibromyalgia. In Fibromyalgia Syndrome; Ablin, J.N., Schoenfeld, Y., Eds.; Springer: Cham, Switzerland, 2021; pp. 59–72. [Google Scholar]
  8. Loftus, N.; Dobbin, N.; Crampton, J.S. The effects of a group exercise and education programme on symptoms and physical fitness in patients with fibromyalgia: A prospective observational cohort study. Disabil. Rehabil. 2021, 1–8. [Google Scholar] [CrossRef]
  9. Pulido-Martos, M.; Luque-Reca, O.; Segura-Jiménez, V.; Álvarez-Gallardo, I.C.; Soriano-Maldonado, A.; Acosta-Manzano, P.; Gavilán-Carrera, B.; McVeigh, J.G.; Geenen, R.; Delgado-Fernández, M.; et al. Physical and psychological paths toward less severe fibromyalgia: A structural equation model. Ann. Phys. Rehabil. Med. 2020, 63, 46–52. [Google Scholar] [CrossRef]
  10. Segura-Jiménez, V.; Borges-Cosic, M.; Soriano-Maldonado, A.; Estévez-López, F.; Álvarez-Gallardo, I.C.; Herrador-Colmenero, M.; Delgado-Fernández, M.; Ruiz, J.R. Association of sedentary time and physical activity with pain, fatigue, and impact of fibromyalgia: The al-Ándalus study. Scand. J. Med. Sci. Sports 2017, 27, 83–92. [Google Scholar] [CrossRef]
  11. Steiner, J.L.; Bigatti, S.M.; Ang, D.C. Trajectory of change in pain, depression, and physical functioning after physical activity adoption in fibromyalgia. J. Health Psychol. 2015, 20, 931–941. [Google Scholar] [CrossRef]
  12. Thieme, K.; Mathys, M.; Turk, D.C. Evidenced-Based Guidelines on the Treatment of Fibromyalgia Patients: Are They Consistent and If Not, Why Not? Have Effective Psychological Treatments Been Overlooked? J. Pain 2017, 18, 747–756. [Google Scholar] [CrossRef] [PubMed]
  13. Murphy, M.H.; Nevill, A.M.; Murtagh, E.M.; Holder, R.L. The effect of walking on fitness, fatness and resting blood pressure: A meta-analysis of randomised, controlled trials. Prev. Med. 2007, 44, 377–385. [Google Scholar] [CrossRef] [PubMed]
  14. Murtagh, E.M.; Nichols, L.; Mohammed, M.A.; Holder, R.; Nevill, A.M.; Murphy, M.H. The effect of walking on risk factors for cardiovascular disease: An updated systematic review and meta-analysis of randomised control trials. Prev. Med. 2015, 72, 34–43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. O’Connor, S.R.; Tully, M.A.; Ryan, B.; Bleakley, C.M.; Baxter, G.D.; Bradley, J.M.; McDonough, S.M. Walking exercise for chronic musculoskeletal pain: Systematic review and meta-analysis. Arch. Phys. Med. Rehabil. 2015, 96, 724–734.E3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. McLoughlin, M.J.; Colbert, L.H.; Stegner, A.J.; Cook, D.B. Are women with fibromyalgia less physically active than healthy women? Med. Sci. Sports Exerc. 2011, 43, 905–912. [Google Scholar] [CrossRef] [Green Version]
  17. Ruiz, J.R.; Segura-Jiménez, V.; Ortega, F.B.; Álvarez-Gallardo, I.C.; Camiletti-Moirón, D.; Aparicio, V.A.; Carbonell-Baeza, A.; Femia, P.; Munguía-Izquierdo, D.; Delgado-Fernández, M. Objectively measured sedentary time and physical activity in women with fibromyalgia: A cross-sectional study. BMJ Open 2013, 3, 1–9. [Google Scholar] [CrossRef] [Green Version]
  18. Estévez-López, F.; Álvarez-Gallardo, I.C.; Segura-Jiménez, V.; Soriano-Maldonado, A.; Borges-Cosic, M.; Pulido-Martos, M.; Aparicio, V.A.; Carbonell-Baeza, A.; Delgado-Fernández, M.; Geenen, R. The discordance between subjectively and objectively measured physical function in women with fibromyalgia: Association with catastrophizing and self-efficacy cognitions. The al-Ándalus project. Disabil. Rehabil. 2018, 40, 329–337. [Google Scholar] [CrossRef]
  19. López-Roig, S.; Pastor, M.Á.; Peñacoba, C.; Lledó, A.; Sanz, Y.; Velasco, L. Prevalence and predictors of unsupervised walking and physical activity in a community population of women with fibromyalgia. Rheumatol. Int. 2016, 36, 1127–1133. [Google Scholar] [CrossRef]
  20. Sanz-Baños, Y.; Pastor-Mira, M.Á.; Lledó, A.; López-Roig, S.; Peñacoba, C.; Sánchez-Meca, J. Do women with fibromyalgia adhere to walking for exercise programs to improve their health? Systematic review and meta-analysis. Disabil. Rehabil. 2018, 40, 2475–2487. [Google Scholar] [CrossRef]
  21. Pastor-Mira, M.A.; López-Roig, S.; Peñacoba, C.; Sanz-Baños, Y.; Lledó, A.; Velasco, L. Predicting walking as exercise in women with fibromyalgia from the perspective of the theory of planned behavior. Women Health 2020, 60, 412–425. [Google Scholar] [CrossRef]
  22. Ang, D.C.; Kaleth, A.S.; Bigatti, S.; Mazzuca, S.A.; Jensen, M.P.; Hilligoss, J.; Slaven, J.; Saha, C. Research to Encourage Exercise for Fibromyalgia (REEF). Clin. J. Pain 2013, 29, 296–304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Vlaeyen, J.W.S.; Linton, S.J. Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain 2000, 85, 317–332. [Google Scholar] [CrossRef] [Green Version]
  24. Nijs, J.; Roussel, N.; Van Oosterwijck, J.; De Kooning, M.; Ickmans, K.; Struyf, F.; Meeus, M.; Lundberg, M. Fear of movement and avoidance behaviour toward physical activity in chronic-fatigue syndrome and fibromyalgia: State of the art and implications for clinical practice. Clin. Rheumatol. 2013, 32, 1121–1129. [Google Scholar] [CrossRef]
  25. Crombez, G.; Eccleston, C.; Van Damme, S.; Vlaeyen, J.W.S.; Karoly, P. Fear-Avoidance Model of Chronic Pain. Clin. J. Pain 2012, 28, 475–483. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Meulders, A. From fear of movement-related pain and avoidance to chronic pain disability: A state-of-the-art review. Curr. Opin. Behav. Sci. 2019, 26, 130–136. [Google Scholar] [CrossRef]
  27. Tabor, A.; Van Ryckeghem, D.M.L.; Hasenbring, M.I. Pain Unstuck: The Role of Action and Motivation. Clin. J. Pain 2020, 36, 143–149. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Van Damme, S.; Crombez, G.; Eccleston, C. Coping with pain: A motivational perspective. Pain 2008, 139, 1–4. [Google Scholar] [CrossRef] [PubMed]
  29. Karsdorp, P.A.; Vlaeyen, J.W.S. Goals matter: Both achievement and pain-avoidance goals are associated with pain severity and disability in patients with low back and upper extremity pain. Pain 2011, 152, 1382–1390. [Google Scholar] [CrossRef]
  30. Karsdorp, P.A.; Nijst, S.E.; Goossens, M.E.J.B.; Vlaeyen, J.W.S. The role of current mood and stop rules on physical task performance: An experimental investigation in patients with work-related upper extremity pain. Eur. J. Pain 2010, 14, 434–440. [Google Scholar] [CrossRef]
  31. Crombez, G.; De Paepe, A.L.; Veirman, E.; Eccleston, C.; Verleysen, G.; Van Ryckeghem, D.M.L. Let’s talk about pain catastrophizing measures: An item content analysis. PeerJ 2020, 2020, e8643. [Google Scholar] [CrossRef]
  32. Amtmann, D.; Liljenquist, K.; Bamer, A.; Bocell, F.; Jensen, M.; Wilson, R.; Turk, D. Measuring Pain Catastrophizing and Pain-Related Self-Efficacy: Expert Panels, Focus Groups, and Cognitive Interviews. Patient 2018, 11, 107–117. [Google Scholar] [CrossRef] [PubMed]
  33. Pastor, M.Á.; López-Roig, S.; Sanz, Y.; Peñacoba, C.; Cigarán, M.; Velasco, L.; Carmen Écija, A.L. Walking as physical exercise in Fibromyalgia: An elicitation study from the Theory of Planned Behavior. An. Psicol. 2015, 31, 433–446. [Google Scholar] [CrossRef] [Green Version]
  34. Conversano, C.; Laura, M.; Rebecca, C.; Mirabelli, V.; Angelo, G. Catastrophizing and Fibromyalgia: A Mini-Review. J. Transl. Neurosci. 2018, 3, 1–4. [Google Scholar] [CrossRef] [Green Version]
  35. Galvez-Sánchez, C.M.; Montoro, C.I.; Duschek, S.; del Paso, G.A.R. Pain catastrophizing mediates the negative influence of pain and trait-anxiety on health-related quality of life in fibromyalgia. Qual. Life Res. 2020, 29, 1871–1881. [Google Scholar] [CrossRef]
  36. Luciano, J.V.; Forero, C.G.; Cerdà-Lafont, M.; Peñarrubia-María, M.T.; Fernández-Vergel, R.; Cuesta-Vargas, A.I.; Ruíz, J.M.; Rozadilla-Sacanell, A.; Sirvent-Alierta, E.; Santo-Panero, P.; et al. Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups. Clin. J. Pain 2016, 32, 829–840. [Google Scholar] [CrossRef]
  37. Martinez-Calderon, J.; Jensen, M.P.; Morales-Asencio, J.M.; Luque-Suarez, A. Pain Catastrophizing and Function in Individuals with Chronic Musculoskeletal Pain. Clin. J. Pain 2019, 35, 279–293. [Google Scholar] [CrossRef]
  38. Rodero, B.; Casanueva, B.; García-Campayo, J.; Roca, M.; Magallán, R.; Lápez Del Hoyo, Y. Stages of chronicity in fibromyalgia and pain catastrophising: A cross-sectional study. BMC Musculoskelet. Disord. 2010, 11, 251. [Google Scholar] [CrossRef] [Green Version]
  39. Estévez-López, F.; Segura-Jiménez, V.; Álvarez-Gallardo, I.C.; Borges-Cosic, M.; Pulido-Martos, M.; Carbonell-Baeza, A.; Aparicio, V.A.; Geenen, R.; Delgado-Fernández, M. Adaptation profiles comprising objective and subjective measures in fibromyalgia: The al-Ándalus project. Rheumatology 2017, 56, 2015–2024. [Google Scholar] [CrossRef] [Green Version]
  40. Westman, A.E.; Boersma, K.; Leppert, J.; Linton, S.J. Fear-Avoidance Beliefs, Catastrophizing, and Distress. Clin. J. Pain 2011, 27, 567–577. [Google Scholar] [CrossRef]
  41. Lazaridou, A.; Paschali, M.; Schreiber, K.; Galenkamp, L.; Berry, M.; Paschalis, T.; Napadow, V.; Edwards, R.R. The association between daily physical exercise and pain among women with fibromyalgia: The moderating role of pain catastrophizing. Pain Rep. 2020, 5, 53–55. [Google Scholar] [CrossRef]
  42. Sullivan, M.; Bishop, S.; Pivik, J. The pain catastrophizing scale: User Manual. Psychol. Assess. 1995, 7, 524–532. [Google Scholar] [CrossRef]
  43. Jensen, M.P.; Turner, L.R.; Turner, J.A.; Romano, J.M. The use of multiple-item scales for pain intensity measurement in chronic pain patients. Pain 1996, 67, 35–40. [Google Scholar] [CrossRef]
  44. Martín-Aragón, M.; Pastor, M.A.; Rodríguez-Martín, J.; March, M.J.; Lledó, A.; López-Roig, S.; Terol, M.C. Dpto de Psicología de la Salud. Facultad de Medicina. Universidad Miguel Hernández. J. Health Psychol. 1999, 11, 53–75. [Google Scholar]
  45. Lledó-Boyer, A.; Pastor-Mira, M.A.; Pons-Calatayud, N.; López-Roig, S.; Rodríguez-Marín, J.; Bruehl, S. Control beliefs, coping and emotions: Exploring relationships to explain fibromyalgia health outcomes. Int. J. Clin. Health Psychol. 2010, 10, 459–476. [Google Scholar]
  46. Pastor-Mira, M.-Á.; López-Roig, S.; Martínez-Zaragoza, F.; Toribio, E.; Nardi-Rodríguez, A.; Peñacoba, C. Motivational Determinants of Objective Physical Activity in Women with Fibromyalgia Who Attended Rehabilitation Settings. J. Clin. Med. 2021, 10, 5547. [Google Scholar] [CrossRef]
  47. Pastor-Mira, M.-A.; López-Roig, S.; Martínez-Zaragoza, F.; León, E.; Abad, E.; Lledó, A.; Peñacoba, C. Goal Preferences, Affect, Activity Patterns and Health Outcomes in Women with Fibromyalgia. Front. Psychol. 2019, 10, 1–15. [Google Scholar] [CrossRef]
  48. Salgueiro, M.; García-Leiva, J.M.; Ballesteros, J.; Hidalgo, J.; Molina, R.; Calandre, E.P. Validation of a Spanish version of the Revised Fibromyalgia Impact Questionnaire (FIQR). Health Qual. Life Outcomes 2013, 11, 132. [Google Scholar] [CrossRef] [Green Version]
  49. IPAQ Group. International Physical Activity Questionnaire Self Administered Short Form (IPAQ-S), Spanish Version. 2011. Available online: https://sites.google.com/site/theipaq/questionnaire_links (accessed on 14 December 2021).
  50. Rivera, J.; Alegre, C.; Carbonell, J.; Ballina, F.J. Documento de consenso de la Sociedad Española de Reumatología sobre la fibromialgia. Reumatol. Clínica 2006, 2, S55–S66. [Google Scholar] [CrossRef]
  51. Ratter, J.; Radlinger, L.; Lucas, C. Several submaximal exercise tests are reliable, valid and acceptable in people with chronic pain, fibromyalgia or chronic fatigue: A systematic review. J. Physiother. 2014, 60, 144–150. [Google Scholar] [CrossRef] [Green Version]
  52. Esteve, R.; Ramírez-Maestre, C.; Peters, M.L.; Serrano-Ibáñez, E.R.; Ruíz-Párraga, G.T.; López-Martínez, A.E. Development and initial validation of the activity patterns scale in patients with chronic pain. J. Pain 2016, 17, 451–461. [Google Scholar] [CrossRef]
  53. Kindermans, H.P.J.; Roelofs, J.; Goossens, M.E.J.B.; Huijnen, I.P.J.; Verbunt, J.A.; Vlaeyen, J.W.S. Activity patterns in chronic pain: Underlying dimensions and associations with disability and depressed mood. J. Pain 2011, 12, 1049–1058. [Google Scholar] [CrossRef] [PubMed]
  54. Wolfe, F.; Clauw, D.J.; Fitzcharles, M.A.; Goldenberg, D.L.; Häuser, W.; Katz, R.L.; Mease, P.J.; Russell, A.S.; Russell, I.J.; Walitt, B. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 2016, 46, 319–329. [Google Scholar] [CrossRef] [PubMed]
  55. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care 2002, 166, 111–117. [CrossRef] [PubMed]
  56. Pastor, M.-Á.; López-Roig, S.; Lledó, A.; Peñacoba, C.; Velasco, L.; Schweiger-Gallo, I.; Cigarán, M.; Écija, C.; Limón, R.; Sanz, Y. Combining motivational and volitional strategies to promote unsupervised walking in patients with fibromyalgia: Study protocol for a randomized controlled trial. Trials 2014, 15, 120. [Google Scholar] [CrossRef] [Green Version]
  57. Sullivan, M.J.L. The Pain Catastrophizing Scale: User Manual; McGill University: Montreal, QC, Canada, 2009. [Google Scholar]
  58. Lazaridou, A.; Franceschelli, O.; Buliteanu, A.; Cornelius, M.; Edwards, R.R.; Jamison, R.N. Influence of catastrophizing on pain intensity, disability, side effects, and opioid misuse among pain patients in primary care. J. Appl. Biobehav. Res. 2017, 22, 1–13. [Google Scholar] [CrossRef] [Green Version]
  59. Osman, A.; Barrios, F.X.; Kopper, B.A.; Hauptmann, W.; Jones, J.; O’Neill, E. Factor structure, reliability, and validity of the pain catastrophizing scale. J. Behav. Med. 1997, 20, 589–605. [Google Scholar] [CrossRef] [PubMed]
  60. Hosmer, D.W.; Lemeshow, S. Applied Logistic Regression, 2nd ed.; Wiley & Sons: New York, NY, USA, 2000. [Google Scholar]
  61. Hayes, A.F. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach, 2nd ed.; The Guildford Press: New York, NY, USA, 2018. [Google Scholar]
  62. Sosa-Reina, M.D.; Nunez-Nagy, S.; Gallego-Izquierdo, T.; Pecos-Martín, D.; Monserrat, J.; Álvarez-Mon, M. Effectiveness of Therapeutic Exercise in Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Biomed. Res. Int. 2017, 2017. [Google Scholar] [CrossRef]
  63. Bidonde, J.; Busch, A.J.; Schachter, C.L.; Overend, T.J.; Kim, S.Y.; Góes, S.M.; Boden, C.; Foulds, H.J. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst. Rev. 2017. [Google Scholar] [CrossRef]
  64. Aldrich, S.; Eccleston, C.; Crombez, G. Worrying about chronic pain: Vigilance to threat and misdirected problem solving. Behav. Res. Ther. 2000, 38, 457–470. [Google Scholar] [CrossRef]
  65. De Vlieger, P.; Van den Bussche, E.; Eccleston, C.; Crombez, G. Finding a solution to the problem of pain: Conceptual formulation and the development of the Pain Solutions Questionnaire (PaSol). Pain 2006, 123, 285–293. [Google Scholar] [CrossRef]
  66. Gatchel, R.J. Introduction to the “Special Issue on Pain Catastrophizing”. J. Appl. Biobehav. Res. 2017, 22, 1–5. [Google Scholar] [CrossRef] [Green Version]
  67. Velasco, L.; López-Gómez, I.; Gutiérrez, L.; Écija, C.; Catalá, P.; Peñacoba, C. Exploring the Preference for Fatigue-avoidance Goals as a Mediator Between Pain Catastrophizing, Functional Impairment and Walking Behavior in Women with Fibromyalgia. Clin. J. Pain 2021. [Google Scholar] [CrossRef] [PubMed]
  68. De Gier, M.; Peters, M.L.; Vlaeyen, J.W.S. Fear of pain, physical performance, and attentional processes in patients with fibromyalgia. Pain 2003, 104, 121–130. [Google Scholar] [CrossRef]
  69. Estévez-López, F.; Rodriguez-Ayllon, M.; Soriano-Maldonado, A.; Acosta-Manzano, P.; Segura-Jiménez, V.; Álvarez-Gallardo, I.C.; Pulido-Martos, M.; Herrador-Colmenero, M.; Geenen, R.; Carbonell-Baeza, A.; et al. Lower Fatigue in Fit and Positive Women with Fibromyalgia: The al-Ándalus Project. Pain Med. 2019, 20, 2506–2515. [Google Scholar] [CrossRef] [PubMed]
  70. Mannerkorpi, K.; Svantesson, U.; Broberg, C. Relationships between performance-based tests and patients’ ratings of activity limitations, self-efficacy, and pain in fibromyalgia. Arch. Phys. Med. Rehabil. 2006, 87, 259–264. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Walking maintenance along the walking task.
Figure 1. Walking maintenance along the walking task.
Ijerph 19 01513 g001
Figure 2. Paths linking pain-related worrying and total walking distance.
Figure 2. Paths linking pain-related worrying and total walking distance.
Ijerph 19 01513 g002
Table 1. Descriptive and difference analysis.
Table 1. Descriptive and difference analysis.
Entire SampleLow Pain-Related WorryingHigh Pain-Related Worrying
n (%)Mean(SD)[95% CI]n (%)Mean(SD)[95% CI]n (%)Mean(SD)[95% CI]t
Pain-related worrying111 (100)30.9(12.3)[28.6–33.2]55 (49.5)20.7(7.8)[18.6–22.8]56(50.5)40.9(6.2)[39.2–42.5]
Age (years) 51.4(9.7)[49.6–53.2] ns
Time from symptoms 14.1(9.8)[12.1–16.0] ns
Time from diagnosis 6.2(6.2)[5.0–7.4] ns
Fatigue intensity b. t.a 7.3(2.2)[6.9–7.7] ns
Pain intensity b. t.a 6.5(2.2)[6.1–6.9] 5.7(2.1)[5.2–6.3] 7.3(2.1)[6.8–7.9]−4.16 ***
Pain intensity 6.8(1.7)[6.5–7.1] 6.1(1.6)[5.7–6.5] 7.4(1.5)[7.0–7.8]−4.68 ***
Fibromyalgia impact 72.3(15.8)[69.3–75.2] 66.0(17.2)[61.4–70.2] 78.4(11.6)[75.3–81.5]−4.44 ***
Goal preferences 4.4(1.3)[4.2–4.7] 4.1(1.4)[3.8–4.5] 4.7(1.2)[4.4–5.1]−2.44 *
Total MET-min/week b 694(1635)[439–873] 856(1701)[509–1506] 384(879)[231–693]4.76 * c
Number of laps 14.3(10.6)[12.3–16.3] 16.4(11.7)[13.2–19.6] 12.3(9.1)[9.8–14.7]2.07 *
Walking distance d:
Total 886(637)[766–1006] 1010(702)[820–1200] 765(546)[619–911]2.05 *
Bout 1111 (100)396(85)[380–412]55 (49.5)420(77)[399–441]56(50.5)372(86)[349–395]3.14 **
Bout 265 (58.6)396(91)[374–419]34 (61.8)423(80)[396–452]31(55.4)366(95)[332–401]2.65 **
Bout 335 (31.5)412(86)[383–442]19 (54.3) 16(45.7) ns
Bout 420 (18.0)425(86)[384–465]13 (65.0) 7 (35.0) ns
Bout 513 (11.7)443(107)[379–508]9 (69.2) 4 (30.8) ns
a = before the task; b = Median (Interquartile Rank); c = npar median test; d = number of meters rounded; * p < 0.05; ** p < 0.01; *** p < 0.001.
Table 2. Logistic regression analyses.
Table 2. Logistic regression analyses.
Stop vs. Walking
Model an bOR[95% CI]pχ2 cCp
1st bout111/46
Goals preference 1.443[1.026–2.030]0.02713.467 **3.28
Fibromyalgia impact 1.029[1.000–1.060]0.037
Educational level 2.428[1.055–5.589]0.033
2nd bout65/30
Goals preference 1.621[1.166–2.255]0.00311.295 **4.04
Educational level 2.300[0.957–5.530]0.058
3rd bout35/10
Goals preference 1.540[1.073–2.210]0.0185.617 *1.78
a: In table only variables in the final equations; b: in each bout: n of participants/n who stopped after the bout; OR = odds ratio; c: test of model coefficient; * p < 0.05 **; p < 0.01.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pastor-Mira, M.Á.; López-Roig, S.; Toribio, E.; Martínez-Zaragoza, F.; Nardi-Rodríguez, A.; Peñacoba, C. Pain-Related Worrying and Goal Preferences Determine Walking Persistence in Women with Fibromyalgia. Int. J. Environ. Res. Public Health 2022, 19, 1513. https://doi.org/10.3390/ijerph19031513

AMA Style

Pastor-Mira MÁ, López-Roig S, Toribio E, Martínez-Zaragoza F, Nardi-Rodríguez A, Peñacoba C. Pain-Related Worrying and Goal Preferences Determine Walking Persistence in Women with Fibromyalgia. International Journal of Environmental Research and Public Health. 2022; 19(3):1513. https://doi.org/10.3390/ijerph19031513

Chicago/Turabian Style

Pastor-Mira, María Ángeles, Sofía López-Roig, Eva Toribio, Fermín Martínez-Zaragoza, Ainara Nardi-Rodríguez, and Cecilia Peñacoba. 2022. "Pain-Related Worrying and Goal Preferences Determine Walking Persistence in Women with Fibromyalgia" International Journal of Environmental Research and Public Health 19, no. 3: 1513. https://doi.org/10.3390/ijerph19031513

APA Style

Pastor-Mira, M. Á., López-Roig, S., Toribio, E., Martínez-Zaragoza, F., Nardi-Rodríguez, A., & Peñacoba, C. (2022). Pain-Related Worrying and Goal Preferences Determine Walking Persistence in Women with Fibromyalgia. International Journal of Environmental Research and Public Health, 19(3), 1513. https://doi.org/10.3390/ijerph19031513

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop